» Articles » PMID: 29375384

The Role of Adenosine Receptors in Psychostimulant Addiction

Overview
Journal Front Pharmacol
Date 2018 Jan 30
PMID 29375384
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Adenosine receptors (AR) are a family of G-protein coupled receptors, comprised of four members, named A, A, A, and A receptors, found widely distributed in almost all human body tissues and organs. To date, they are known to participate in a large variety of physiopathological responses, which include vasodilation, pain, and inflammation. In particular, in the central nervous system (CNS), adenosine acts as a neuromodulator, exerting different functions depending on the type of AR and consequent cellular signaling involved. In terms of molecular pathways and second messengers involved, A and A receptors inhibit adenylyl cyclase (AC), through G proteins, while A and A receptors stimulate it through G proteins. In the CNS, A receptors are widely distributed in the cortex, hippocampus, and cerebellum, A receptors are localized mainly in the striatum and olfactory bulb, while A and A receptors are found at low levels of expression. In addition, AR are able to form heteromers, both among themselves (e.g., A/A), as well as with other subtypes (e.g., A/D), opening a whole range of possibilities in the field of the pharmacology of AR. Nowadays, we know that adenosine, by acting on adenosine A and A receptors, is known to antagonistically modulate dopaminergic neurotransmission and therefore reward systems, being A receptors colocalized in heteromeric complexes with D receptors, and A receptors with D receptors. This review documents the present state of knowledge of the contribution of AR, particularly A and A, to psychostimulants-mediated effects, including locomotor activity, discrimination, seeking and reward, and discuss their therapeutic relevance to psychostimulant addiction. Studies presented in this review reinforce the potential of A agonists as an effective strategy to counteract psychostimulant-induced effects. Furthermore, different experimental data support the hypothesis that A/D heterodimers are partly responsible for the psychomotor and reinforcing effects of psychostimulant drugs, such as cocaine and amphetamine, and the stimulation of A receptor is proposed as a potential therapeutic target for the treatment of drug addiction. The overall analysis of presented data provide evidence that excitatory modulation of A and A receptors constitute promising tools to counteract psychostimulants addiction.

Citing Articles

Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons.

Ngo H, Srivastava A, Le H, Ayer S, Crotty G, Schwarzschild M BMC Neurosci. 2025; 26(1):19.

PMID: 40038582 PMC: 11877714. DOI: 10.1186/s12868-025-00939-7.


An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission.

Akyuz E, Arulsamy A, Aslan F, Sarisozen B, Guney B, Hekimoglu A Mol Neurobiol. 2024; 62(2):1631-1674.

PMID: 39012443 PMC: 11772559. DOI: 10.1007/s12035-024-04333-y.


Caffeine Inhibits Both Basal and Insulin-Activated Urate Transport.

Mandal A, Merriman T, Choi H, Mount D Arthritis Rheumatol. 2024; 76(11):1658-1669.

PMID: 38932509 PMC: 11562663. DOI: 10.1002/art.42940.


Adenosine A and dopamine D receptor interaction controls fatigue resistance.

Alves A, Santos N, Santos A, da Panatta G, Speck A, Cunha R Front Pharmacol. 2024; 15:1390187.

PMID: 38860172 PMC: 11163034. DOI: 10.3389/fphar.2024.1390187.


Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons.

Ngo H, Le H, Ayer S, Crotty G, Schwarzschild M, Bakshi R Res Sq. 2024; .

PMID: 38562908 PMC: 10984011. DOI: 10.21203/rs.3.rs-4076333/v1.


References
1.
Meyerhof W, Richter D . Molecular cloning of a novel putative G-protein coupled receptor expressed during rat spermiogenesis. FEBS Lett. 1991; 284(2):155-60. DOI: 10.1016/0014-5793(91)80674-r. View

2.
Ferre S, Fredholm B, Morelli M, Popoli P, Fuxe K . Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 1997; 20(10):482-7. DOI: 10.1016/s0166-2236(97)01096-5. View

3.
Harper L, Beckett S, Marsden C, McCreary A, Alexander S . Effects of the A 2A adenosine receptor antagonist KW6002 in the nucleus accumbens in vitro and in vivo. Pharmacol Biochem Behav. 2006; 83(1):114-21. DOI: 10.1016/j.pbb.2005.12.014. View

4.
Justinova Z, Ferre S, Segal P, Antoniou K, Solinas M, Pappas L . Involvement of adenosine A1 and A2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of cocaine and methamphetamine in rats. J Pharmacol Exp Ther. 2003; 307(3):977-86. DOI: 10.1124/jpet.103.056762. View

5.
Silberberg G, Bolam J . Local and afferent synaptic pathways in the striatal microcircuitry. Curr Opin Neurobiol. 2015; 33:182-7. DOI: 10.1016/j.conb.2015.05.002. View